Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

0.44p
   
  • Change Today:
    -0.015p
  • 52 Week High: 1.15
  • 52 Week Low: 0.39
  • Currency: UK Pounds
  • Shares Issued: 203.21m
  • Volume: 981,837
  • Market Cap: £0.89m
  • RiskGrade: 504

Physiomics Overview

Physiomics’ vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -58.4% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.2 n/a
Pr/Book 1.3  
Latest F'cast
Revenue 44.3% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Physiomics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-21 0.70 (0.34) (0.22)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.83 (0.36) (0.26)p n/a n/a n/a n/a 0.0%
30-Jun-23 0.60 (0.57) (0.49)p n/a n/a n/a n/a 0.0%
30-Jun-24 0.54 (0.67) (0.45)p n/a n/a n/a n/a 0.0%
30-Jun-25 0.78 (0.46) (0.17)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Physiomics Company Announcements

Change of Registered Office 30-Sep-2025 07:00 RNS
Annual Financial Report 29-Sep-2025 07:00 RNS
Notice of Results and Investor Presentation 22-Sep-2025 07:00 RNS

Physiomics ShareCast News

Physiomics scores new contract with long standin... 16-Jul-2025 ShareCast
Physiomics total income grows in FY25, pre-tax l... 14-Jul-2025 ShareCast
Physiomics secures two new contracts, names head... 16-Jun-2025 ShareCast

Latest Physiomics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Physiomics Market Data

Currency UK Pounds
Share Price 0.44p
Change Today -0.015p
% Change -3.30 %
52 Week High 1.15
52 Week Low 0.39
Volume 981,837
Shares Issued 203.21m
Market Cap £0.89m
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.89% below the market average22.89% below the market average22.89% below the market average22.89% below the market average22.89% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average
Price Trend
71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Income Not Available
Growth
54.04% below the market average54.04% below the market average54.04% below the market average54.04% below the market average54.04% below the market average
82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average

Physiomics Dividends

No dividends found

Trades for 07-Oct-2025

Time Volume / Share Price
14:13 216,523 @ 0.46p
13:50 2,083 @ 0.48p
13:08 750,000 @ 0.43p
11:46 1,233 @ 0.43p
08:28 11,998 @ 0.45p

Physiomics Key Personnel

CEO Peter Sargent

Top of Page